Dual Antiplatelet Therapy (DAPT) versus No Antiplatelet Therapy and Incidence of Major Bleeding in Patients on Venoarterial Extracorporeal Membrane Oxygenation

Open Access

Peer-reviewed

Research Article

Dawid L. Staudacher ,

* E-mail: dawid.staudacher@universitaets-herzzenrum.de

Affiliation Heart Center Freiburg University, Department of Cardiology and Angiology I, Freiburg, Germany

http://orcid.org/0000-0002-9423-9682

⨯
Paul M. Biever,

Affiliation Heart Center Freiburg University, Department of Cardiology and Angiology I, Freiburg, Germany
⨯
Christoph Benk,

Affiliation Heart Center Freiburg University, Department of Cardiovascular Surgery, Freiburg, Germany
⨯
Ingo Ahrens,

Affiliation Heart Center Freiburg University, Department of Cardiology and Angiology I, Freiburg, Germany
⨯
Christoph Bode,

Affiliation Heart Center Freiburg University, Department of Cardiology and Angiology I, Freiburg, Germany
⨯
Tobias Wengenmayer

Affiliation Heart Center Freiburg University, Department of Cardiology and Angiology I, Freiburg, Germany
⨯

Reader Comments (0)

Hemorrhage
Is the Subject Area "Hemorrhage" applicable to this article?

Thanks for your feedback.
Antiplatelet therapy
Is the Subject Area "Antiplatelet therapy" applicable to this article?

Thanks for your feedback.
Blood transfusion
Is the Subject Area "Blood transfusion" applicable to this article?

Thanks for your feedback.
Platelets
Is the Subject Area "Platelets" applicable to this article?

Thanks for your feedback.
Blood plasma
Is the Subject Area "Blood plasma" applicable to this article?

Thanks for your feedback.
Red blood cells
Is the Subject Area "Red blood cells" applicable to this article?

Thanks for your feedback.
Anticoagulant therapy
Is the Subject Area "Anticoagulant therapy" applicable to this article?

Thanks for your feedback.
Heparin
Is the Subject Area "Heparin" applicable to this article?

Thanks for your feedback.